Filings (90d)
Other insiders active in the same sector
No other insider has filed at Michael W. Dunne's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Darren M. Black - $77.56M in LFST purchases and sales in the last 12 months
- Noubar Afeyan - $75.00M in GENB purchases and sales in the last 12 months
- Andrew J. Mills - $75.00M in MDLN purchases and sales in the last 12 months
- Charles N. Mills - $74.80M in MDLN purchases and sales in the last 12 months
- Keith A. Meister - $74.03M in WGS purchases and sales in the last 12 months
- Warren B. Kanders - $73.88M in CDRE purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Michael W. Dunne?
Michael W. Dunne is a corporate insider of Iterum Therapeutics plc (ITRM). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Michael W. Dunne last file a Form 4?
The most recent primary Form 4 on record is dated 20 November 2025, one of 2 filings going back to 2025.
Has Michael W. Dunne been buying or selling stock?
Recorded transactions: 2 open-market purchases ($13K) and 0 open-market sales across all tracked filings.
